Hemostatic Disorders in Women and Girls Colloquium (Uterine Hemostasis Colloquium III)

March 9, 2021

Hemostatic Disorders in Women and Girls Colloquium (Uterine Hemostasis Colloquium III)

Date: March 9, 2021 (Held preceding HTRS/NASTH 2021)

Time: 9:30 am – 12:30 pm ET

FWGBD wishes to thank our 2021 Colloquium Industry Partners and Collaborator. Please click on the links below to view our partners and collaborator, as well items in our Colloquium’s virtual tote bag: 

Thank You to Our Industry Partners

Virtual Tote Bag


Our biennial colloquium on uterine hemostatic disorders convened leading faculty/researchers/clinicians to review our current understanding of the science and evidence-based practice related to the diagnosis and clinical management of abnormal uterine hemostasis.

The educational goals for this meeting are:

  1. Convene top experts in the fields of Obstetrics/Gynecology and in Hematology, who are working in uterine hemostasis and blood disorders in women and girls.
  2. Review the state of the science with respect to normal uterine hemostasis.
  3. Recognize the range of complications related to abnormal uterine hemostasis.
  4. Describe and review the epidemiology and variability in phenotype regarding women with hemophilia.
  5. Examine the full range of options for achieving uterine hemostasis in women with acute abnormal uterine bleeding, postpartum hemorrhage, and bleeding and clotting disorders including thrombotic microangiopathies.
  6. Develop and disseminate a summary of what was discussed regarding the state-of-the- science in hemostatic disorders in women and girls and identify research gaps.
  7. Effectively disseminate best practices in the care of women with abnormal uterine bleeding, hemophilia, postpartum hemorrhage, and thrombotic microangiopathies.
  8. Describe, and underscore for target healthcare providers, the intersection of obstetrics/gynecology and hematology in the optimal care of these women and develop mechanisms for facilitating the collaboration of these specialties.

Faculty Information

The recording and archiving of this activity was supported in part through a medical education grant from Grifols.

 Welcome and Opening Remarks – Faculty: Andra H. James, MD, MPH

Presentation I: Uterine Hemostasis Overview – Faculty: Andra H. James, MD, MPH

Presentation II: Women & Girls with Hemophilia – Faculty: Sarah H. O’Brien, MD, MSc

Presentation III: Management of Delivery in Women with Hemophilia – Faculty: Andra H. James, MD, MPH

Presentation IV: Thrombosis and Exogenous Hormones – Faculty: Naomi K. Tepper, MD, MPH, FACOG

Presentation V: Is It HELLP Syndrome? Is It TTP? Is It Atypical HUS? Does it Matter? Thrombotic Microangiopathies in Pregnancy – Faculty: Gow M. Arepally, MD

Q & A Session, Wrap – Up

 To come